China Pharma Holdings (CPHI) Q4 2021 Earnings Report

292 Followers

CPHI Q4 2021 EPS Results

Actual EPS-$10.87

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$8.41

Actual Revenue$1.60M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-45.28%

QuarterQ4 2021

Date03/31/2022

TimeBefore Open

Conference CallThursday, March 31, 2022

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
May 15, 2025	2025 (Q1)	- / -0.24	-0.728	66.90% (+0.49)
May 16, 2024	2024 (Q1)	- / -0.07	-0.295	75.25% (+0.22)
Nov 17, 2023	2023 (Q3)	- / -0.06	-0.158	62.66% (+0.10)
Aug 17, 2023	2023 (Q2)	- / -0.06	-0.183	67.21% (+0.12)
May 12, 2023	2023 (Q1)	- / -2.95	-10.865	72.89% (+7.92)
Mar 31, 2023	2022 (Q4)	- / -0.20	-0.207	3.86% (<+0.01)
Nov 18, 2022	2022 (Q3)	- / -0.02	-0.018	11.11% (<+0.01)
Aug 18, 2022	2022 (Q2)	- / -0.02	-0.018	0.00% (0.00)
Mar 31, 2022	2021 (Q4)	- / -10.87	-8.415	-29.11% (-2.45)
Nov 12, 2021	2021 (Q3)	- / -8.98	-1.158	-675.91% (-7.83)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed